Search

everythinglearnresearchcommunity

for

Search:↓

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

New compounds show promise as nonsteroidal treatments for hair loss.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

MC-1R is present in skin cells and may help reduce inflammation.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

A new engineered treatment shows promise in curing heart fibrosis.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Finding functions for unknown GPCRs is hard but key for making new drugs.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.